Transplantation
From the Journals
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
From the Journals
REACH2: Ruxolitinib outperformed control treatment for refractory acute GVHD
Ruxolitinib was significantly more effective against acute graft-versus-host disease but produced more thrombocytopenia than did control treatment...
Latest News
Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapy
From the Journals
CAR T-cell therapy may worsen mental health in some patients
From the Journals
Several factors may drive recent improvements in allo-HCT outcomes
Patients transplanted in recent years were older and sicker at baseline but had better outcomes than did patients transplanted in the mid-2000s....
Conference Coverage
PT-Cy bests conventional GVHD prophylaxis
ORLANDO – Rates of progression/relapse, progression-free survival, and overall survival were similar between posttransplant cyclophosphamide and...
Conference Coverage
Myeloma patients over age 70 can benefit from auto-HC transplant
ORLANDO – Researchers said all myeloma patients should be referred a transplant center, regardless of age.
From the Journals
Case-control study IDs several novel risk factors of post-HCT melanoma
Feature
First NCCN guideline on hematopoietic cell transplantation focuses on GVHD
Diagnosis and management of both acute and chronic graft-versus-host disease is at the core of the recommendations.
From the Journals
Hematopoietic cell transplant offers realistic cure in secondary AML
The observational trial showed that survival was significantly higher with transplant than with chemotherapy consolidation therapy in patients...